1.Löffler W. Zur differential-diagnose der lungeninfiltrierungen. Il uber fluchtige succedan-infiltrate (mit eosinophilie). Beitr Klin Tuberk 1932;79:368-92.

2.Crofton JW, Livingstone JL, Oswald NC, Roberts AT. Pulmonary eosinophilia. Thorax 1952;7:1-35.

3.Reeder WH, Goodrich BE. Pulmonary infiltration with eosinophilia (PIE syndrome). Ann Intern Med 1952;36: 1217-40.

4.Cottin V, Cordier J-F. Eosinophilic pneumonias. Allergy 2005;60:841-57.

5.Marchand E, Cordier JF. Idiopathic chronic eosinophilic pneumonia. Semin Respir Crit Care Med 2006;27:134- 41.

6.Thomeer MJ, Costabe U, Rizzato G, Poletti V, Demedts M. Comparison of registries of interstitial lung diseases in three European countries. Eur Respir J Suppl 2001; 32:114s-8s.

7.Marchand E, Reynaud-Gaubert M, Lauque D, Durieu J, Tonnel AB, Cordier JF. Idiopathic chronic eosinophilic pneumonia. A clinical follow-up study of 62 cases. The Groupe d'Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM“O”P). Medicine (Baltimore) 1998;77:299-312.

8.Jeong YJ, Kim KI, Seo IJ, Lee CH, Lee KN, Kim KN, et al. Eosinophilic lung diseases: a clinical, radiologic, and pathologic overview. Radiographics 2007;27:617- 39.

9.Marchand E, Etienne-Mastroianni B, Chanez P, Lauque D, Leclerc P, Cordier JF. Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Eur Respir J 2003;22:8-13.

10.Durieu J, Wallaert B, Tonnel AB. Long-term follow-up of pulmonary function in chronic eosinophilic pneumonia. Groupe d'Etude en Pathologie Interstitielle de la Societe de Pathologie Thoracique du Nord. Eur Respir J 1997;10:286-91.

11.Badesch DB, King TE Jr, Schwarz MI. Acute eosinophilic pneumonia: a hypersensitivity phenomenon? Am Rev Respir Dis 1989;139:249-52.

12.Allen JN, Pacht ER, Gadek JE, Davis WB. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 1989;321: 569-74.

13.Philit F, Etienne-Mastroianni B, Parrot A, Guerin C, Robert D, Cordier JF. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med 2002;166:1235-9.

14.Daimon T, Johkoh T, Sumikawa H, Honda O, Fujimoto K, Koga T, et al. Acute eosinophilic pneumonia: thin-section CT findings in 29 patients. Eur J Radiol 2008;65:462-7.

15.Rom WN, Weiden M, Garcia R, Yie TA, Vathesatogkit P, Tse DB, et al. Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust. Am J Respir Crit Care Med 2002;166: 797-800.

16.Shorr AF, Scoville SL, Cersovsky SB, Shanks GD, Ockenhouse CF, Smoak BL, et al. Acute eosinophilic pneumonia among US military personnel deployed in or near Iraq. JAMA 2004;292:2997-3005.

17.Pope-Harman AL, Davis WB, Allen ED, Christoforidis AJ, Allen JN. Acute eosinophilic pneumonia. A summary of 15 cases and review of the literature. Medicine (Baltimore) 1996;75:334-42.

18.Allen J. Acute eosinophilic pneumonia. Semin Respir Crit Care Med 2006;27:142-7.

19.Hardy WR, Anderson RE. The hypereosinophilic syndrome. Ann Intern Med 1968;68:1220-9.

20.Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic, syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975;54: 1-27.

21.Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003;348:1201-14.

22.Kilon AD, Robyn J, Akin C, Noel P, Brown M, Law M, et al. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood 2004;103:473-8.

23.Cogan E, Schandene´ L, Crusiaux A, Cochaux P, Velu T, Goldman M. Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 1994;330:535-8.

24.Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH. The idiopathic hypereosinophilic syndrome: clinical, pathophysiologic and therapeutic considerations. Ann Intern Med 1982;97:78-92.

25.Roufosse F, Goldman M, Cogan E. Hypereosinophilic syndrome: lymphoproliferative and myeloproliferative variants. Semin Respir Crit Care Med 2006;27:158-70.

26.Roufosse F, Cogan E, Goldman M. Recent advances in pathogenesis and management of hypereosinophilic syndromes. Allergy 2004;59:673-89.

27.Hinson KF, Moon AJ, Plummer NS. Broncho-pulmonary aspergillosis; a review and a report of eight new cases. Thorax 1952;7:317-33.

28.Pepys A. Hypersensitivity diseases of the lung due to fungi and organic dusts. In: Karger S, editor. Monographs in allergy. Basel, Switzerland: S. Karger; 1969.

29.Tillie-Leblond I, Tonnel AB. Allergic bronchopulmonary aspergillosis. Allergy 2005;60:1004-13.

30.Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002;110:685-92.

31.Proceedings of the Cystic Fibrosis Foundation ABPA consensus conference. Bethesda, Md: 2001 Jun 12-13. Bethesda, Md: North American Cystic Fibrosis Foundation, 2002.

32.Patterson R, Greenberger PA, Radin RC, Roberts M. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann Intern Med 1982;96:286-91.

33.Hemmann S, Menz G, Ismail C, Blaser K, Crameri R. Skin test reactivity to 2 recombinant Aspergillus fumigatus allergens in A fumigatus-sensitized asthmatic subjects allows diagnostic separation of allergic bronchopulmonary aspergillosis from fungal sensitization. J Allergy Clin Immunol 1999;104:601-7.

34.Malo JL, Inouye T, Hawkins R, Simon G, Turner- Warwick M, Pepys J. Studies in chronic allergic bronchopulmonary aspergillosis. 4. Comparison with a group of asthmatics. Thorax 1977;32:275-80.

35.Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzard A, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000;342:756-62.

36.Wark PA, Hensley MJ, Saltos N, Boyle MJ, Toneguzzi RC, Epid GD, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003;111:952-7.

37.Hong ST. Gungnae gisaengchung gamnyeomjeungui hyeonhwang. J Korean Med Assoc 1998;41:737-45.

38.Chai JY. Food－borne parasitic diseases. J Korean Med Assoc 2004;47:496-507.

39.Shin S. Parasitic zoonosis transmitted by pet animals.J Korean Med Assoc 2004;47:527-34.

40.Chitkara RK, Krishna G. Parasitic pulmonary eosinophilia. Semin Respir Crit Care Med 2006;27:171-84.

41.Solomon J, Schwarz M. Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia. Semin Respir Crit Care Med 2006;27:192-7.

42.Kilbourne EM, Rigau-Perez JG, Heath CW Jr. Clinical epidemiology of toxic-oil syndrome. Manfestations of a new illness. N Engl J Med 1983;309:1408-14.

43.Alonso-Ruiz A, Calabozo M, Perez-Ruiz F, Mancebo L. Toxic oil syndrome. A long-term follow-up of a cohort of 332 patients. Medicine (Baltimore) 1993;72:285-95.

44.Silver RM, Heyes MP, Maize JC, Quearry B, Vionnet- Fuasset M, Sternberg EM. Scleroderma, fascities, and eosinophilia associated with the ingestion of tryptophan. N Engl J Med 1990;322:874-81.

45.Cottin V, Frognier R, Monnot H. Chronic eosinophilic pneumonia after radiation therapy for breast cancer. Eur Respir J 2004;23:9-13.